Tuesday, Feb 20 2018 | Updated at 10:30 AM EST

Stay Connected With Us F T R

LBS-002

University Of Sydney Gets Exclusive License For Brain Cancer Medicine

Mar 27, 2017 PM EDT Lin BioScience confirms an exclusive license agreement with the University of Sydney for a very promising brain cancer drug.

Real Time Analytics